This site is intended for UK HCPs* and ORDMs** and is brought to you by Pfizer Ltd.

Menu

Close

Great BritainComirnaty Omicron XBB.1.5 30 mcgCOMIRNATY Omicron XBB.1.5 10mcgCOMIRNATY Omicron XBB.1.5  3mcgNorthern IrelandComirnaty Omicron XBB.1.5 30mcgCOMIRNATY Omicron XBB.1.5 10mcgCOMIRNATY  Omicron XBB.1.5 3mcg
Sorry, we can't find that page right now. 

You may have followed a broken link or there may be an error on our site. If you typed in a URL, please make sure you have typed it correctly. 

PP-CMR-GBR-0233 September 2023

Marketing Authorisation
Holder: BioNTech
Manufacturing GmbH

COMIRNATY, COMIRNATY Omicron XBB.1.5, COMIRNATY Original/Omicron BA.4-5 and COMIRNATY Original/Omicron BA.1 COVID-19 mRNA Vaccines, which are based on BioNTech proprietary mRNA technology, were developed by both BioNTech and Pfizer.


©2024 Pfizer Inc. All rights reserved. PP-CMR-GBR-0522  February 2024

*Healthcare Professionals ** Other Relevant Decision Makers

The product information provided in this site is intended only for Healthcare Professionals and Other Relevant Decision Makers resident in the United Kingdom. 

This website is brought to you by Pfizer Limited, a company registered in England and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent CT13 9NJ, VAT registration number GB201048427.

The products discussed may have different product labelling in other countries.​​​​​​​
​​​​​​​